Literature DB >> 19847204

Mechanisms controlling titer and expression of bidirectional lentiviral and gammaretroviral vectors.

T Maetzig1, M Galla, M H Brugman, R Loew, C Baum, A Schambach.   

Abstract

Bidirectional lentiviral vectors mediate expression of two or more cDNAs from a single internal promoter. In this study, we examined mechanisms that control titer and expression properties of this vector system. To address whether the bidirectional design depends on lentiviral (LV) backbone components, especially the Rev/Rev responsive element (RRE) system, we constructed similar expression cassettes for LV and gammaretroviral (GV) vectors. Bidirectional expression levels could be adjusted by the use of different internal promoters. Furthermore, removal of the constitutive RNA transport element of Mason-Pfizer monkey virus, used in first generation bidirectional LV vectors, improved gene expression. Titers of bidirectional vectors were approximately 10-fold reduced in comparison to unidirectional vectors, independent of the Rev/RRE interaction. We reasoned that titer reductions were due to the formation of interfering double-stranded RNA in packaging cells. Indeed, cotransfection of Nodamuravirus B2 protein, an RNA interference suppressor, increased bidirectional vector titers at least fivefold. We validated the potential of high titer bidirectional vectors by coexpressing a fluorescent marker with O(6)-methylguanine-DNA methyltransferase from integrating, or with Cre recombinase from integrating and non-integrating GV and LV backbones. This allowed for the tracking of chemoprotected and recombined cells by fluorescence marker expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19847204     DOI: 10.1038/gt.2009.129

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  17 in total

Review 1.  Zinc-finger nucleases for somatic gene therapy: the next frontier.

Authors:  Shamim H Rahman; Morgan L Maeder; J Keith Joung; Toni Cathomen
Journal:  Hum Gene Ther       Date:  2011-07-22       Impact factor: 5.695

2.  Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements.

Authors:  Annalisa Lattanzi; Vasco Meneghini; Giulia Pavani; Fatima Amor; Sophie Ramadier; Tristan Felix; Chiara Antoniani; Cecile Masson; Olivier Alibeu; Ciaran Lee; Matthew H Porteus; Gang Bao; Mario Amendola; Fulvio Mavilio; Annarita Miccio
Journal:  Mol Ther       Date:  2018-10-17       Impact factor: 11.454

3.  Self-inactivating alpharetroviral vectors with a split-packaging design.

Authors:  Julia D Suerth; Tobias Maetzig; Melanie Galla; Christopher Baum; Axel Schambach
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

4.  Sustained knockdown of a disease-causing gene in patient-specific induced pluripotent stem cells using lentiviral vector-based gene therapy.

Authors:  Reto Eggenschwiler; Komal Loya; Guangming Wu; Amar Deep Sharma; Malte Sgodda; Daniela Zychlinski; Christian Herr; Doris Steinemann; Jeffrey Teckman; Robert Bals; Michael Ott; Axel Schambach; Hans Robert Schöler; Tobias Cantz
Journal:  Stem Cells Transl Med       Date:  2013-08-07       Impact factor: 6.940

5.  miR-9 is a tumor suppressor in pediatric AML with t(8;21).

Authors:  S Emmrich; J E Katsman-Kuipers; K Henke; M E Khatib; R Jammal; F Engeland; F Dasci; C M Zwaan; M L den Boer; L Verboon; J Stary; A Baruchel; V de Haas; A A Danen-van Oorschot; M Fornerod; R Pieters; D Reinhardt; J H Klusmann; M M van den Heuvel-Eibrink
Journal:  Leukemia       Date:  2013-11-25       Impact factor: 11.528

Review 6.  Gammaretroviral vectors: biology, technology and application.

Authors:  Tobias Maetzig; Melanie Galla; Christopher Baum; Axel Schambach
Journal:  Viruses       Date:  2011-06-03       Impact factor: 5.048

7.  Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery.

Authors:  Melanie Galla; Axel Schambach; Christine S Falk; Tobias Maetzig; Johannes Kuehle; Kathrin Lange; Daniela Zychlinski; Niels Heinz; Martijn H Brugman; Gudrun Göhring; Zsuzsanna Izsvák; Zoltán Ivics; Christopher Baum
Journal:  Nucleic Acids Res       Date:  2011-05-23       Impact factor: 16.971

8.  Multigenic lentiviral vectors for combined and tissue-specific expression of miRNA- and protein-based antiangiogenic factors.

Authors:  Anne Louise Askou; Lars Aagaard; Corinne Kostic; Yvan Arsenijevic; Anne Kruse Hollensen; Toke Bek; Thomas Gryesten Jensen; Jacob Giehm Mikkelsen; Thomas Juhl Corydon
Journal:  Mol Ther Methods Clin Dev       Date:  2015-01-28       Impact factor: 6.698

9.  Genetic deletion of SEPT7 reveals a cell type-specific role of septins in microtubule destabilization for the completion of cytokinesis.

Authors:  Manoj B Menon; Akihiro Sawada; Anuhar Chaturvedi; Pooja Mishra; Karin Schuster-Gossler; Melanie Galla; Axel Schambach; Achim Gossler; Reinhold Förster; Michael Heuser; Alexey Kotlyarov; Makoto Kinoshita; Matthias Gaestel
Journal:  PLoS Genet       Date:  2014-08-14       Impact factor: 5.917

10.  miR-99a/100~125b tricistrons regulate hematopoietic stem and progenitor cell homeostasis by shifting the balance between TGFβ and Wnt signaling.

Authors:  Stephan Emmrich; Mareike Rasche; Jennifer Schöning; Christina Reimer; Sarva Keihani; Aliaksandra Maroz; Ying Xie; Zhe Li; Axel Schambach; Dirk Reinhardt; Jan-Henning Klusmann
Journal:  Genes Dev       Date:  2014-04-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.